Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1CNS 1Breast 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Glioma 1Gastrointestinal Stromal Tumors 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6Temozolomide 3Biopsy 3Bevacizumab 3posaconazole 2fluciclovine F-18 2Topotecan 2Specimen Handling 2Radiosurgery 2Pemetrexed 2Nivolumab 2Methotrexate 2Ketoconazole 2Fluorodeoxyglucose F18 2ribociclib 1relatlimab 1mycophenolic adenine dinucleotide 1montelukast 1gancotamab 1fluoromisonidazole 1fluorodopa F 18 1fludarabine phosphate 1etoposide phosphate 1eribulin 1dexamethasone acetate 1dexamethasone 21-phosphate 1clevudine 1ceritinib 1brivaracetam 1auricularum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Brain Neoplasms × 68Ga-NOTA-RM26 × Clear all
NCT05549024 2024-07-05

68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
90 enrolled
BreastCNSGenitourinary

Brain Neoplasms, Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡